[ | E-mail ] Contact: ESMO Press Officemedia@esmo.orgEuropean Society for Medical Oncology@myesmo High-dose radiotherapy adds no survival benefit after chemotherapy and radical surgery; PD-L1 protein a possible immunotherapy target Treating patients with high-dose radiotherapy after…
Source:Studies report new findings on treatment options for mesothelioma
No comments:
Post a Comment